STOCKHOLM, Sweden, Sept. 7, 2005 (PRIMEZONE) -- Elekta has published its Annual Report for fiscal year 2003/04. The report is available on www.elekta.com together with other documentation for the Annual General Meeting and also on www.waymaker.se.
The Annual Report gives an overview of today's Elekta, a comprehensive provider of clinical solutions and information systems for treating cancer and brain disorders.
In April 2005, Elekta acquired IMPAC Medical Systems, Inc. enabling Elekta to offer its customers a new broad range of medical IT systems for use in cancer care. The acquisition is an important addition to the Elekta Group and means that the company is ready to embrace the next phase in Elekta's development.
In addition to presenting IMPAC's operations and the Elekta's extensive program for customer support -- Elekta Lifecycle Services -- the Annual Report gives extensive insight in Elekta's six solution classifications:
-- Precision Radiation Therapy -- Image Guided Radiation Therapy -- Stereotactic Radiation Therapy -- Gamma Knife(R) surgery -- Stereotactic Neurosurgery -- Functional Mapping
"Looking strategically ahead on a longer time horizon, it is clear that Elekta will continue its process of transformation from being primarily a supplier of equipment to becoming a comprehensive partner to the healthcare sector, delivering systems, clinical solutions and services for the entire treatment process within oncology and neurosurgery," writes Tomas Puusepp, President and CEO in the President's comments.
To request hardcopies of the Annual Report, please send an e-mail to ir@elekta.com.
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(r) for non-invasive treatment of brain disorders and Elekta Synergy(r) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1,700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For additional information about Elekta, please visit www.elekta.com.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=128444&fn=wkr0001.pdf PDF version (of this release)